Gefitinib Completed Phase 3 Trials for Neoplasms / Carcinoma NOS / Non-Small-Cell Lung / Metastases Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00034879Iressa Expanded Access Program (EAP)